With 2022 came the success of Lecanemab, a new drug that’s instilled hope for those affected by Alzheimer’s.
With 2022 came the success of Lecanemab, a new drug that’s instilled hope for those affected by Alzheimer’s. With nearly 50 million people worldwide diagnosed with Alzheimer’s (or related dementia), the disease has become an increasingly prominent concern, pushing research for a medical solution.